Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to -$14.9 million.

  • Sanara MedTech's Enterprise Value rose 998.82% to -$14.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.9 million, marking a year-over-year increase of 998.82%. This contributed to the annual value of -$16.4 million for FY2024, which is 20362.57% down from last year.
  • Sanara MedTech's Enterprise Value amounted to -$14.9 million in Q3 2025, which was up 998.82% from -$17.0 million recorded in Q2 2025.
  • Sanara MedTech's Enterprise Value's 5-year high stood at -$3.1 million during Q1 2024, with a 5-year trough of -$27.8 million in Q1 2021.
  • For the 5-year period, Sanara MedTech's Enterprise Value averaged around -$14.0 million, with its median value being -$14.9 million (2025).
  • Its Enterprise Value has fluctuated over the past 5 years, first tumbled by 239963.6% in 2021, then surged by 5819.19% in 2024.
  • Sanara MedTech's Enterprise Value (Quarter) stood at -$19.1 million in 2021, then soared by 52.63% to -$9.1 million in 2022, then skyrocketed by 40.53% to -$5.4 million in 2023, then plummeted by 203.63% to -$16.4 million in 2024, then grew by 8.69% to -$14.9 million in 2025.
  • Its Enterprise Value stands at -$14.9 million for Q3 2025, versus -$17.0 million for Q2 2025 and -$20.7 million for Q1 2025.